Blue Chip India Limited (NSE:BLUECHIP)

Akoya Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.29	0.48	0.11	0.18	0.22
Short-Term Investments	-	0.04	0.04	0.04	0.04
Trading Asset Securities	0.06	0.06	0.06	0.06	0.06
Cash & Short-Term Investments	0.35	0.59	0.21	0.29	0.32
Cash Growth	-39.86%	175.59%	-25.78%	-10.59%	183.86%
Other Receivables	-	26.03	-	-	-
Receivables	27.89	41.94	16.38	24.36	24.35
Other Current Assets	1.12	1.41	0.99	0.92	0.91
Total Current Assets	45	43.94	17.59	25.57	25.58
Property, Plant & Equipment	0.11	0.11	0.11	0.11	0.11
Long-Term Investments	6.16	7.32	61.46	58.96	31.39
Other Intangible Assets	0.01	0.01	0.01	0.01	0.01
Long-Term Deferred Tax Assets	-	15.63	15.63	15.63	15.63
Other Long-Term Assets	-	-	0	-	-
Total Assets	51.27	67.01	94.8	100.28	72.72
Accounts Payable	-	-	0	-	-
Other Current Liabilities	0.47	46.73	46.89	1.08	0.57
Total Current Liabilities	0.47	46.73	46.89	1.08	0.57
Other Long-Term Liabilities	57.74	-	-	60.48	58.28
Total Liabilities	58.21	46.73	46.89	61.55	58.85
Common Stock	110.61	110.61	110.61	110.61	110.61
Additional Paid-In Capital	-	27.39	27.39	-	27.39
Retained Earnings	-	-185.83	-156.46	-	-160.86
Comprehensive Income & Other	-117.54	68.11	66.37	-71.88	36.72
Shareholders' Equity	-6.93	20.28	47.91	38.73	13.86
Total Liabilities & Equity	51.27	67.01	94.8	100.28	72.72
Net Cash (Debt)	0.35	0.59	0.21	0.29	0.32
Net Cash Growth	-39.86%	175.59%	-25.78%	-10.59%	183.86%
Net Cash Per Share	0.01	0.01	0.00	0.01	0.01
Filing Date Shares Outstanding	54.81	55.3	55.3	55.3	55.3
Total Common Shares Outstanding	54.81	55.3	55.3	55.3	55.3
Working Capital	44.53	-2.79	-29.3	24.49	25.01
Book Value Per Share	-0.13	0.37	0.87	0.70	0.25
Tangible Book Value	-6.94	20.28	47.91	38.72	13.86
Tangible Book Value Per Share	-0.13	0.37	0.87	0.70	0.25
Machinery	-	4.06	4.06	4.06	4.06

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.